Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Time for this forum to get back on track.

One option that may have been overlooked is the reaction to the notification of potential infringement: an internal analysis of the claim.

At what point does the stated increasing cost of a license outweigh holding out to see how things go at the USPTO?

If a company's EEs determine that there is merit to the alleged infringement, isn't payment of a license fee more justified, based on available information filed with the USPTO, before the outcome, as done by over 70 licensees to date?

.

.

.

Be well

Share
New Message
Please login to post a reply